Company / Return on Equity (ROE)
Enveric Biosciences, Inc. Return on Equity (ROE) History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-86.9%
FY2019
5-year range
-86.9% / -23.8%
FY2017-FY2019
Trend
-
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Enveric Biosciences, Inc. reports negative total equity of -86.9% in FY2019. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-86.9% in FY2019.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2019 | -86.9% | - |
| FY2018 | - | - |
| FY2017 | -23.8% | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026